GSK's office-space overhaul part of bigger changes

GlaxoSmithKline ($GSK) employees in the Philadelphia area face big changes in the way they work as the company prepares to relocate to a new building in the Navy Yard. But those changes are only part of the U.K.-based company's operational shifts. Job cuts, compensation changes and realigned marketing strategies are just some of the others. Report

Suggested Articles

The FDA has granted Amarin's Vascepa a possible blockbuster label expansion for CV risk reduction in patients with or without CV disease.

In a high-stakes patent lawsuit between CAR-T companies Bristol-Myers Squibb and Gilead Sciences, BMS has come up with a victory. 

It’s been a year of ups and downs for Pfizer’s Xeljanz. But the company is hoping to close on a high note, with help from a new extended-release pill.